102 related articles for article (PubMed ID: 8929747)
1. Further elucidation of pharmacokinetic interaction between diltiazem and warfarin.
Stoysich AM; Lucas BD; Mohiuddin SM; Hilleman DE
Int J Clin Pharmacol Ther; 1996 Feb; 34(2):56-60. PubMed ID: 8929747
[TBL] [Abstract][Full Text] [Related]
2. Effect of montelukast on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.
Van Hecken A; Depré M; Verbesselt R; Wynants K; De Lepeleire I; Arnout J; Wong PH; Freeman A; Holland S; Gertz B; De Schepper PJ
J Clin Pharmacol; 1999 May; 39(5):495-500. PubMed ID: 10234597
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic and pharmacodynamic interactions between diltiazem and quinidine.
Laganière S; Davies RF; Carignan G; Foris K; Goernert L; Carrier K; Pereira C; McGilveray I
Clin Pharmacol Ther; 1996 Sep; 60(3):255-64. PubMed ID: 8841148
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic interaction between warfarin and a uricosuric agent, bucolome: application of In vitro approaches to predicting In vivo reduction of (S)-warfarin clearance.
Takahashi H; Kashima T; Kimura S; Murata N; Takaba T; Iwade K; Abe T; Tainaka H; Yasumori T; Echizen aH
Drug Metab Dispos; 1999 Oct; 27(10):1179-86. PubMed ID: 10497145
[TBL] [Abstract][Full Text] [Related]
5. Bisoprolol: studies of potential interactions with theophylline and warfarin in healthy volunteers.
Warrington SJ; Johnston A; Lewis Y; Murphy M
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S164-8. PubMed ID: 11527121
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a potential tigecycline-warfarin drug interaction.
Zimmerman JJ; Raible DG; Harper DM; Matschke K; Speth JL
Pharmacotherapy; 2008 Jul; 28(7):895-905. PubMed ID: 18576904
[TBL] [Abstract][Full Text] [Related]
7. Clofibrate displaces warfarin from plasma proteins in man: an example of a pure displacement interaction.
Bjornsson TD; Meffin PJ; Swezey S; Blaschke TF
J Pharmacol Exp Ther; 1979 Sep; 210(3):316-21. PubMed ID: 480183
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of effects of terbinafine on single oral dose pharmacokinetics and anticoagulant actions of warfarin in healthy volunteers.
Guerret M; Francheteau P; Hubert M
Pharmacotherapy; 1997; 17(4):767-73. PubMed ID: 9250555
[TBL] [Abstract][Full Text] [Related]
9. Probable interaction between warfarin and marijuana smoking.
Yamreudeewong W; Wong HK; Brausch LM; Pulley KR
Ann Pharmacother; 2009 Jul; 43(7):1347-53. PubMed ID: 19531696
[TBL] [Abstract][Full Text] [Related]
10. The effect of rofecoxib on the pharmacodynamics and pharmcokinetics of warfarin.
Schwartz JI; Bugianesi KJ; Ebel DL; De Smet M; Haesen R; Larson PJ; Ko A; Verbesselt R; Hunt TL; Lins R; Lens S; Porras AG; Dieck J; Keymeulen B; Gertz BJ
Clin Pharmacol Ther; 2000 Dec; 68(6):626-36. PubMed ID: 11180023
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of warfarin metabolism by diltiazem in humans.
Abernethy DR; Kaminsky LS; Dickinson TH
J Pharmacol Exp Ther; 1991 Apr; 257(1):411-5. PubMed ID: 2020000
[TBL] [Abstract][Full Text] [Related]
12. The absence of an interaction between warfarin and cranberry juice: a randomized, double-blind trial.
Ansell J; McDonough M; Zhao Y; Harmatz JS; Greenblatt DJ
J Clin Pharmacol; 2009 Jul; 49(7):824-30. PubMed ID: 19553405
[TBL] [Abstract][Full Text] [Related]
13. Effect of rosuvastatin on warfarin pharmacodynamics and pharmacokinetics.
Simonson SG; Martin PD; Mitchell PD; Lasseter K; Gibson G; Schneck DW
J Clin Pharmacol; 2005 Aug; 45(8):927-34. PubMed ID: 16027403
[TBL] [Abstract][Full Text] [Related]
14. Absence of a pharmacokinetic interaction between etanercept and warfarin.
Zhou H; Patat A; Parks V; Buckwalter M; Metzger D; Korth-Bradley J
J Clin Pharmacol; 2004 May; 44(5):543-50. PubMed ID: 15102876
[TBL] [Abstract][Full Text] [Related]
15. Lack of pharmacokinetic and pharmacodynamic interactions between a smoking cessation therapy, varenicline, and warfarin: an in vivo and in vitro study.
Burstein AH; Clark DJ; O'Gorman M; Willavize SA; Brayman TG; Grover GS; Walsky RL; Obach RS; Faessel HM
J Clin Pharmacol; 2007 Nov; 47(11):1421-9. PubMed ID: 17962429
[TBL] [Abstract][Full Text] [Related]
16. Ciprofloxacin prolonged-release tablets do not affect warfarin pharmacokinetics and pharmacodynamics.
Washington C; Hou SY; Hughes NC; Campanella C; Berner B
J Clin Pharmacol; 2007 Oct; 47(10):1320-6. PubMed ID: 17724088
[TBL] [Abstract][Full Text] [Related]
17. Potential interaction between warfarin and high dietary protein intake.
Hornsby LB; Hester EK; Donaldson AR
Pharmacotherapy; 2008 Apr; 28(4):536-9. PubMed ID: 18363537
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic and pharmacodynamic interactions between simvastatin and diltiazem in patients with hypercholesterolemia and hypertension.
Watanabe H; Kosuge K; Nishio S; Yamada H; Uchida S; Satoh H; Hayashi H; Ishizaki T; Ohashi K
Life Sci; 2004 Dec; 76(3):281-92. PubMed ID: 15531380
[TBL] [Abstract][Full Text] [Related]
19. Does celecoxib potentiate the anticoagulant effect of warfarin? A randomized, double-blind, controlled trial.
Dentali F; Douketis JD; Woods K; Thabane L; Foster G; Holbrook A; Crowther M
Ann Pharmacother; 2006; 40(7-8):1241-7. PubMed ID: 16804099
[TBL] [Abstract][Full Text] [Related]
20. Interaction between paracetamol and warfarin in patients: a double-blind, placebo-controlled, randomized study.
Mahé I; Bertrand N; Drouet L; Bal Dit Sollier C; Simoneau G; Mazoyer E; Caulin C; Bergmann JF
Haematologica; 2006 Dec; 91(12):1621-7. PubMed ID: 17145598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]